Sutro Biopharma, Inc. (STRO)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Sutro Biopharma, Inc. (STRO)
Go deeper and ask any question about STRO
Company Performance
Current Price
as of Sep 13, 2024$4.50
P/E Ratio
N/A
Market Cap
$368.84M
Description
Sutro Biopharma, Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA.
Metrics
Overview
- HQSouth San Francisco, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerSTRO
- Price$4.5+1.12%
Trading Information
- Market Cap$368.84M
- Float92.54%
- Average Daily Volume (1m)596,582
- Average Daily Volume (3m)763,126
- EPS-$1.84
Company
- Revenue$169.36M
- Rev Growth (1yr)146.89%
- Net Income-$48.02M
- Gross Margin93.04%
- EBITDA Margin-182.43%
- EBITDA-$46.90M
- EV$2.43M
- EV/Revenue0.01
- P/EN/A
- P/S2.16
Documents
SEC Filings
Factset Street Account